Related Experiment Video
Updated: Dec 13, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts
Karun Neupane1, Zahoor Ahmed2, Hira Pervez3
1Internal Medicine, Manipal College of Medical Sciences, Pokhara, NPL.
Abstract:
Coronavirus disease-2019 (COVID-19), first reported in China during December of 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection later spread very rapidly around the globe with over 8,708,008 cases reported, including more than 461,715 deaths reported across at least 216 countries by June 20, 2020. It was declared as a global pandemic by the World Health Organization (WHO) on March 11, 2020. With the rapidly increasing number of positive cases and deaths, there is a dire need for effective treatment. An urgent unmet need led to the planning and opening of multiple drug development trials for treatment and vaccine development. In this article, we have compiled comprehensive data on many candidate drugs such as remdesivir, favipiravir, ribavirin, umifenovir, arbidol, lopinavir, ritonavir, baricitinib, hydroxychloroquine, nitazoxanide, azithromycin, baloxavir, oseltamivir, losartan, and tocilizumab. We have tabulated available data on various clinical trials testing various aspects of COVID-19 therapeutics.
Insights
The COVID-19 pandemic necessitates effective treatments. This article reviews data from clinical trials on candidate drugs like remdesivir and hydroxychloroquine for treating SARS-CoV-2 infection.
Area of Science:
- Infectious Diseases
- Virology
- Pharmacology
Background:
- Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, rapidly became a global pandemic.
- Over 8.7 million cases and 461,000 deaths were reported globally by June 20, 2020.
- The escalating crisis created an urgent need for effective COVID-19 therapeutics.
Purpose of the Study:
- To compile comprehensive data on candidate drugs for COVID-19 treatment.
- To review clinical trial data for various therapeutic agents.
- To provide an overview of ongoing drug development for SARS-CoV-2.
Main Methods:
- Literature review and data compilation.
- Tabulation of data from clinical trials on COVID-19 therapeutics.
- Analysis of candidate drugs including remdesivir, favipiravir, hydroxychloroquine, and others.
Main Results:
- A comprehensive list of candidate drugs for COVID-19 treatment is presented.
- Data from multiple clinical trials investigating these drugs are tabulated.
- The article covers a wide range of therapeutic agents being tested against SARS-CoV-2.
Conclusions:
- Multiple drug development trials are underway for COVID-19 treatment.
- Effective therapeutic options are crucial for managing the pandemic.
- This compilation serves as a resource for understanding current COVID-19 therapeutic research.
Related Concept Videos
Preclinical Development: Overview
Drug Discovery: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials: Overview
Microorganisms in Medicine and Therapeutics
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

